A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer

Oncology Research and Treatment
Teresa MoranRafael Rosell

Abstract

Second primary malignancies (SPM) in the lung are not common in breast cancer (BC) patients. EGFR-mutant lung cancer (LC) is a separate molecular subset, and the co-existence of EGFR-mutant LC and BC has not been explored. We hypothesized that EGFR-mutant LC patients could have higher rates of primary BC than those with EGFR-wild type (WT). We collected data on clinical and molecular characteristics and outcomes of female patients with LC and a previous or simultaneous history of primary BC treated in our hospital from 2008 to 2014. Data on treatment, follow-up, and EGFR mutation status were available for 356 patients. 17.7% (11/62) of patients with EGFR mutations had BC, compared to 1.02% (3/294) of EGFR-WT patients (p < 0.001). Both tumors were metachronous in 81.8%, with LC diagnosed 9 years after the diagnosis of BC. 5 of the 6 (83.3%) BC patients treated with radiotherapy developed LC in an area within the radiation field. No EGFR mutations were detected in BC tissue and no HER2 expression was detected in LC samples. SPM in the lung and breast occur more frequently among EGFR-mutant compared to EGFR-WT LC patients. Radiotherapy for BC may increase the risk of developing primary LC.

References

Jul 3, 1999·Cancer·F LeviC La Vecchia
Jun 2, 2006·The Journal of Pathology·J S Reis-FilhoF C Schmitt
Mar 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael SchaapveldFlora E van Leeuwen
May 3, 2008·Mayo Clinic Proceedings·Julian R MolinaAlex A Adjei
Aug 21, 2009·The New England Journal of Medicine·Rafael RosellUNKNOWN Spanish Lung Cancer Group
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria G RasoIgnacio I Wistuba
Jan 26, 2010·Journal of Women's Health·Seung Won OhWoong Ju
Feb 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G SlatoreEmily White
Jan 12, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·C Kent OsborneMark Sellers
Jan 26, 2011·Cancer·Christine BouchardyElisabetta Rapiti
Sep 17, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Susana LinLih-Ann Li
May 9, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ruitong XuYongqian Shu
Aug 25, 2012·Cancer Causes & Control : CCC·Sara J SchonfeldAmy Berrington de González
Oct 18, 2012·Breast Cancer Research and Treatment·Hiroko MasudaNaoto T Ueno
Oct 12, 2013·The Journal of Pathology·Brian D Lehmann, Jennifer A Pietenpol
Jan 21, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hideharu KimuraKazuto Nishio
Jul 23, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Vasiliki MichalareaJames Spicer
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Jan 27, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Long JiangJianxing He
May 12, 2016·South Asian Journal of Cancer·Amitabh JenaMandyam Kumaraswamy Reddy
May 19, 2017·Journal of the National Comprehensive Cancer Network : JNCCN·Kilian E Salerno

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.